Western Standard LLC
Western Standard LLC latest Q4_2020 13F filings reported $87,166,000 in market value on this 2021-02-16 report date . The portfolio quarterly return is -1.01%. This fund has 30 securities concentrations of 100% weights.
Western Standard LLC largest holding is Merrimack Pharmaceuticals Inc. with weight of 8.00% and $6,970,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.
Portfolio Performance History
|FILE DATE||REPORT PERIOD||QTR YEAR||FILE TYPE||NOS. OF STOCKS||REPORTED VALUE||RETURN|